HomeInternationalEurope endorsed the use of Pfizer in children aged 5 to 11

Europe endorsed the use of Pfizer in children aged 5 to 11

- Advertisment -

Europe endorsed the use of Pfizer in children aged 5 to 11

The European Medicines Agency (EMA) supported on Thursday the extension of the current European license of the pharmaceutical companies Pfizer and BioNTech for the use of their vaccine against covid-19 in children between 5 and 11 years old, although with a dose lower than the one used in people over 12 years old.

“The vaccine was 90.7% effective in preventing symptomatic covid-19 (although the actual rate could be between 67.7% and 98.3%).”

The injection will be administered in two doses, with an interval of three weeks between the first and the second, underlines the agency in a statement, in which it notes that the benefits of vaccinating children in that age group with Pfizer outweigh the risks .

This conclusion, reached today by the Committee for Medicinal Products for Human Use (CHMP), will be immediately sent to the European Commission, which is the one that has the last word on the licensing of the vaccines authorized in the European campaigns.

The most common side effects found in clinical trials were similar to those in those 12 years of age and older, including tiredness, muscle and headache pain, chills, discomfort, and redness at the injection site – effects that are typically “ mild or moderate ”and improve within a few days of vaccination.

The main study in almost 2000 children aged 5 to 11 years, with no signs of previous infection, showed that the “immune response to Comirnaty (brand name of the vaccine), administered at a lower dose in this age group, was comparable to the one observed with the highest dose in people aged 16 to 25, based on the level of antibodies “against the coronavirus.

Pfizer’s is the first vaccine to receive support from European scientists to be administered to children under 11 years of age, although the pharmaceutical company Moderna also asked the EMA to evaluate the possible use of its vaccine in children between 6 and 11 years of age, which it is still being studied by the CHMP.

in details

The European Medicines Agency (EMA) supported on Thursday the extension of the current European license of the pharmaceutical companies Pfizer and BioNTech for the use of their vaccine against covid-19 in children between 5 and 11 years old, although with a dose lower than the one used in people over 12 years old.

“The vaccine was 90.7% effective in preventing symptomatic covid-19 (although the actual rate could be between 67.7% and 98.3%).”

The injection will be administered in two doses, with an interval of three weeks between the first and the second, underlines the agency in a statement, in which it notes that the benefits of vaccinating children in that age group with Pfizer outweigh the risks .

This conclusion, reached today by the Committee for Medicinal Products for Human Use (CHMP), will be immediately sent to the European Commission, which is the one that has the last word on the licensing of the vaccines authorized in the European campaigns.

The most common side effects found in clinical trials were similar to those in those 12 years of age and older, including tiredness, muscle and headache pain, chills, discomfort, and redness at the injection site – effects that are typically “ mild or moderate ”and improve within a few days of vaccination.

The main study in almost 2000 children aged 5 to 11 years, with no signs of previous infection, showed that the “immune response to Comirnaty (brand name of the vaccine), administered at a lower dose in this age group, was comparable to the one observed with the highest dose in people aged 16 to 25, based on the level of antibodies “against the coronavirus.

Pfizer’s is the first vaccine to receive support from European scientists to be administered to children under 11 years of age, although the pharmaceutical company Moderna also asked the EMA to evaluate the possible use of its vaccine in children between 6 and 11 years of age, which it is still being studied by the CHMP.

, for more latest world update’s, scroll down page
#Europe #endorsed #Pfizer #children #aged

- Advertisment -

Most Popular

- Advertisment -

Recent Comments